Company / Interest Expense
PALVELLA THERAPEUTICS, INC. Interest Expense History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$430.0K
FY2024
5-year range
$0 / $430.0K
FY2023-FY2024
Trend
-
vs FY2023
Sector context
#37 of 44
Health Care
What the data says
PALVELLA THERAPEUTICS, INC.'s interest expense of $430,000 is lower than 84% of companies in the Health Care sector (FY2024).
Based on SEC 10-K filings.
$430,000 in FY2024.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 44This company $430.0K Sector average $291.0M
▼
-99.9% below sector average
Key checks
Key Insights
- Ranks #37 out of 44 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- Strong profit margin: 43.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $430.0K | - |
| FY2023 | $0 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 30, 2026